Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination - PubMed (original) (raw)
Review
doi: 10.1189/jlb.0907649. Epub 2008 Apr 3.
Affiliations
- PMID: 18388299
- DOI: 10.1189/jlb.0907649
Review
Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination
Alexandre Iannello et al. J Leukoc Biol. 2008 Jul.
Abstract
As is the case in other viral infections, humans respond to HIV infection by activating their NK cells. However, the virus uses several strategies to neutralize and evade the host's NK cell responses. Consequently, it is not surprising that NK cell functions become compromised in HIV-infected individuals in early stages of the infection. The compromised NK cell functions also adversely affect several aspects of the host's antiviral adaptive immune responses. Researchers have made significant progress in understanding how HIV counters NK cell responses of the host. This knowledge has opened new avenues for immunotherapy and vaccination against this infection. In the first part of this review article, we gave an overview of our current knowledge of NK cell biology and discussed how the genes encoding NK cell receptors and their ligands determine innate genetic resistance/susceptibilty of humans against HIV infections and AIDS. In this second part, we discuss NK cell responses, viral strategies to counter these responses, and finally, their implications for anti-HIV immunotherapy and vaccination.
Similar articles
- Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
Iannello A, Debbeche O, Samarani S, Ahmad A. Iannello A, et al. J Leukoc Biol. 2008 Jul;84(1):1-26. doi: 10.1189/jlb.0907650. Epub 2008 Apr 3. J Leukoc Biol. 2008. PMID: 18388298 Review. - Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
Terunuma H, Deng X, Dewan Z, Fujimoto S, Yamamoto N. Terunuma H, et al. Int Rev Immunol. 2008;27(3):93-110. doi: 10.1080/08830180801911743. Int Rev Immunol. 2008. PMID: 18437601 Review. - Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.
Ahmad A, Alvarez F. Ahmad A, et al. J Leukoc Biol. 2004 Oct;76(4):743-59. doi: 10.1189/jlb.0304197. Epub 2004 Jun 24. J Leukoc Biol. 2004. PMID: 15218054 Review. - NK cells in HIV infection: paradigm for protection or targets for ambush.
Fauci AS, Mavilio D, Kottilil S. Fauci AS, et al. Nat Rev Immunol. 2005 Nov;5(11):835-43. doi: 10.1038/nri1711. Nat Rev Immunol. 2005. PMID: 16239902 Review. - Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.
Gupta N, Arthos J, Khazanie P, Steenbeke TD, Censoplano NM, Chung EA, Cruz CC, Chaikin MA, Daucher M, Kottilil S, Mavilio D, Schuck P, Sun PD, Rabin RL, Radaev S, Van Ryk D, Cicala C, Fauci AS. Gupta N, et al. Virology. 2005 Feb 20;332(2):491-7. doi: 10.1016/j.virol.2004.12.018. Virology. 2005. PMID: 15680414
Cited by
- Mapping the interplay between NK cells and HIV: therapeutic implications.
Anderko RR, Mailliard RB. Anderko RR, et al. J Leukoc Biol. 2023 Feb 1;113(2):109-138. doi: 10.1093/jleuko/qiac007. J Leukoc Biol. 2023. PMID: 36822173 Free PMC article. Review. - A Natural Impact: NK Cells at the Intersection of Cancer and HIV Disease.
Lucar O, Reeves RK, Jost S. Lucar O, et al. Front Immunol. 2019 Aug 14;10:1850. doi: 10.3389/fimmu.2019.01850. eCollection 2019. Front Immunol. 2019. PMID: 31474977 Free PMC article. Review. - Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
Liu D, Tian S, Zhang K, Xiong W, Lubaki NM, Chen Z, Han W. Liu D, et al. Protein Cell. 2017 Dec;8(12):861-877. doi: 10.1007/s13238-017-0415-5. Epub 2017 May 9. Protein Cell. 2017. PMID: 28488245 Free PMC article. Review. - Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates.
Mikulak J, Di Vito C, Zaghi E, Mavilio D. Mikulak J, et al. Front Immunol. 2017 Mar 23;8:314. doi: 10.3389/fimmu.2017.00314. eCollection 2017. Front Immunol. 2017. PMID: 28386256 Free PMC article. Review. - Alterations of the NK cell pool in HIV/HCV co-infection.
Kaczmarek DJ, Kokordelis P, Krämer B, Glässner A, Wolter F, Goeser F, Lutz P, Schwarze-Zander C, Boesecke C, Strassburg CP, Rockstroh JK, Spengler U, Nattermann J. Kaczmarek DJ, et al. PLoS One. 2017 Apr 5;12(4):e0174465. doi: 10.1371/journal.pone.0174465. eCollection 2017. PLoS One. 2017. PMID: 28380039 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials